Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership

SHENZHEN, China, June 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases
(HTDS.PK) www.htdsmedical.com - announced today that the Company is in the
process of recovering intellectual property (IP) rights that could provide an
enormous financial benefit to the Company.
The Company retained a USA based IP consultant to attempt to recover certain
intellectual property, which the current management, preferred shareholder and
its corporate advisors, verily believe was inappropriately converted by the
previous management of HTDS. Current HTDS management has been informed by the
IP consultant, that the process of converting 100% of the ownership rights
back to HTDS is underway.
The IP rights shall provide the Company with immediate revenue producing
division and access to an industry with substantial potential and high profit
margins. Due to the global demand and need of the process and products of
these intellectual property rights, HTDS is poised to take advantage of every
situation and in short order.
Terry Yuan, CEO of HTDS, stated, "HTDS is fortunate to have talented
management, consultants and advisors together with the financial resources and
backing, required to enable the pursuit of this opportunity; which could
produce an immediate positive financial impact for our shareholders. With
HTDS' global presence, numerous locations and structured divisions, we are
prepared to capitalize on the ownership rights of the recovered intellectual
property rights on a global scale."
"The assertion of these ownership rights is a financial windfall to HTDS,"
stated Keith Roberts, financial advisor - consultant to HTDS. He added, "We
discovered, through our forensic due diligence after the appointment of the
new management and the backing of the preferred shareholder - majority
stakeholders that the 'IP' rights are being utilized by a fully reporting
OTCBB publicly traded company. It is interesting to note that their revenue
model is based solely on these IP rights."
Mr.Roberts continued, "HTDS has many options with respect to the IP rights.
For example we can operate a division ourselves, joint venture with an
experienced third party (receive royalties), or sell these rights with
beneficial terms. No matter the decision; we are coming from a position of
strength that our shareholders could soon recognize. I also serve as a
financial advisor - consultant to several other Pink Sheet issuers, and we
have witnessed these types of activities in the past, where assets and IP
simply go missing or vanish altogether without a trace of paperwork. I know
that the HTDS financial backers, advisors, and preferred shareholders are in a
litigation mode and will vigorously pursue relief through legal means failing
quick resolution of this IP matter. Notwithstanding, HTDS management is
hopeful and anticipates the process of finalizing ownership rights will be
resolved rather quickly and deciding on the direction of the division shortly
thereafter."
The management acknowledges the cooperation and assistance of Mr.Colm King.
In other company news, the company recently retained Mina Mar Group to assist
in completing and filing the "Adequate Disclosure" documents with Pink Sheets
in order to comply with Pink Sheets ranking system. The company is aiming to
achieve a "Current Insurer Status" ranking, being an upgrade (the highest
level at it's tier) from the current "Yield Limited Information which HTDS is
currently ranked at. HTDS has also retained a USA based securities qualified
barrister to review these filings and to have the barrister express a legal
opinion on these filings. Once shortly completed the company will file the
legal opinion with Pink Sheets as well which should suffice in the company
obtaining the "Current Insurer Status" ranking. Near future plans include
completing a financial audit and becoming an SEC reporting issuer which are
one of the first steps towards up listing to the OTCBB. The company advisors
and its management are of the opinion that HTDS share values are grossly
undervalued. The management remains optimistic that the aforementioned
transparency, compliance, audit and the up listing plans will all transform
into a higher valuation and mutually benefit both the company and all
shareholders of HTDS.
The company will provide further details as they become available.

Safe Harbor Statement:

Statements contained herein that are not historical fact may be
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are
subject to a variety of risks and uncertainties. There are a number of
important factors that could cause actual results to differ materially from
those projected or suggested in any forward-looking statements made by HTDS.
These factors include, but are not limited to: (i) the ability of HTDS to
successfully continue to raise financing, (ii) the ability of HTDS to repay
its existing indebtedness, and (iii) the ability of HTDS to successfully
estimate opportunities in certain markets. HTDS does not undertake any
obligation to publicly update any forward-looking statement to reflect events
or circumstances after the date on which any such statement is made or to
reflect the occurrence of unanticipated events.

CONTACT: For any corporate matters, please contact corporate@htdsmedical.com.
CONTACT: For any corporate matters, please contact corporate@htdsmedical.com

SOURCE Hard to Treat Diseases

For any corporate matters, please contact corporate@htdsmedical.com